I see many patients every week who are struggling with symptoms like tremors, stiffness, and walking problems
Blood pressure, cholesterol, and inflammation improvements predict cardiovascular benefitbut predictions don't always materialize
Both semaglutide and tirzepatide are GLP-1 analogues that have shown significant efficacy in weight management
At 68 weeks, participants lost an average of 16% of their body weight, slightly exceeding the STEP 1 results
Drug interactions : Semaglutide's effect on gastric emptying may alter the absorption of oral medications, particularly those with narrow therapeutic indices
Implants are selected based on your new body proportions for results that feel balanced rather than disproportionate